Ajanta Pharma Share Price

<p>Conference Call with Ajanta Pharma Management and Analysts on Q2FY27 Performance and Outlook. Listen to the <a href="https://youtu.be/vrv4cYJW00U">full earnings transcript</a>.</p>

• Trendlyne
• 1 day 23 hours ago

Pls find enclosed Audio recording of Earnings Call

• BSE India
• 1 day 23 hours ago

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Ajanta Pharma announced Q2FY27 results</strong></span><br /> <strong data-complete="true" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_1a"><!--TgQPHd|||[]--></strong><!--TgQPHd|||[]--></h3> <p><strong data-complete="true" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_1i">Consolidated Financial Highlights:<!--TgQPHd|||[]--></strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAICxAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VEfGuf_1o"> <li data-complete="true" data-hveid="CAAICxAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_1p"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_1r">Revenue from operations:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue from operations reached Rs 1,794.16 crore, growing 10.35% QoQ from Rs 1,625.96 crore in Q1FY27 and increasing 32.53% YoY from Rs 1,353.73 crore in Q2FY26. For H1FY27, revenue from operations stood at Rs 3,420.12 crore, up 28.75% compared to Rs 2,656.36 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_1x"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_1z">Total income:<!--TgQPHd|||[]--></strong> For Q2FY27, total income climbed to Rs 1,831.55 crore, registering an increase of 7.94% QoQ against Rs 1,696.86 crore in Q1FY27 and growing 29.61% YoY from Rs 1,413.07 crore in Q2FY26. For H1FY27, total income achieved was Rs 3,528.41 crore, reflecting a growth of 28.68% over Rs 2,742.05 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_25"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_27">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT was Rs 535.15 crore, increasing 19.77% QoQ from Rs 446.80 crore in Q1FY27 and moving up 57.02% YoY against Rs 340.81 crore in Q2FY26. For H1FY27, PBT reached Rs 981.95 crore, up 46.13% relative to Rs 671.94 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_2d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_2f">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT stood at Rs 388.14 crore, which is a QoQ expansion of 16.13% from Rs 334.22 crore in Q1FY27 and a YoY expansion of 49.18% over Rs 260.19 crore in Q2FY26. For H1FY27, PAT reached Rs 722.36 crore, showing a turnaround growth of 40.12% compared to Rs 515.53 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_2l"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_2n">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> For Q2FY27, basic EPS was Rs 31.07 and diluted EPS was Rs 31.03, showing an upgrade QoQ from basic EPS of Rs 26.75 and diluted EPS of Rs 26.72 in Q1FY27. Compared to Q2FY26 where basic EPS was Rs 20.83 and diluted EPS was Rs 20.82, basic EPS rose YoY by 49.16%. For H1FY27, basic EPS reached Rs 57.81 and diluted EPS reached Rs 57.76, growing 40.08% over basic EPS of Rs 41.27 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong data-complete="true" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_2w">Standalone Financial Highlights:<!--TgQPHd|||[]--></strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAIDhAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VEfGuf_32"> <li data-complete="true" data-hveid="CAAIDhAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_33"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_35">Revenue from operations:<!--TgQPHd|||[]--></strong> For Q2FY27, standalone revenue from operations was Rs 1,725.07 crore, up 15.88% QoQ from Rs 1,488.67 crore in Q1FY27 and up 41.37% YoY from Rs 1,220.24 crore in Q2FY26. For H1FY27, revenue from operations amounted to Rs 3,213.74 crore, representing an increase of 32.32% over Rs 2,428.80 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDhAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_3b"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_3d">Total income:<!--TgQPHd|||[]--></strong> For Q2FY27, total income reached Rs 1,777.69 crore, growing 13.99% QoQ from Rs 1,559.49 crore in Q1FY27 and increasing 37.24% YoY from Rs 1,295.27 crore in Q2FY26. For H1FY27, total income stood at Rs 3,337.18 crore, marking a growth of 31.15% relative to Rs 2,544.46 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDhAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_3j"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_3l">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT was Rs 522.62 crore, increasing 23.42% QoQ from Rs 423.45 crore in Q1FY27 and moving up 62.34% YoY from Rs 321.97 crore in Q2FY26. For H1FY27, PBT reached Rs 946.07 crore, showing a 45.33% growth compared to Rs 650.96 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDhAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_3r"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_3t">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT stood at Rs 379.89 crore, rising 20.42% QoQ from Rs 315.47 crore in Q1FY27 and up 52.24% YoY over Rs 249.53 crore in Q2FY26. For H1FY27, PAT arrived at Rs 695.35 crore, scaling up by 37.83% from Rs 504.50 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDhAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_3z"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_41">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> For Q2FY27, basic EPS was Rs 30.40 and diluted EPS was Rs 30.37, expanding QoQ from basic EPS of Rs 25.25 and diluted EPS of Rs 25.22 in Q1FY27. Compared to basic EPS of Rs 19.98 and diluted EPS of Rs 19.97 in Q2FY26, basic EPS grew YoY by 52.15%. For H1FY27, basic EPS was Rs 55.65 and diluted EPS was Rs 55.60, expanding 37.78% over basic EPS of Rs 40.39 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong data-complete="true" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4a">Business Highlights<!--TgQPHd|||[]--></strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAIERAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VEfGuf_4g"> <li data-complete="true" data-hveid="CAAIERAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_4h"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4j">Segment Performance:<!--TgQPHd|||[]--></strong><!--TgQPHd|||[]--> <ul data-complete="true" data-hveid="CAAIERAC" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VEfGuf_4k"> <li data-complete="true" data-hveid="CAAIERAD" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_4l"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4n">India Branded Generics:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue stood at Rs 504 crore, increasing 16.67% QoQ from Rs 504 crore Wait, let's look at the table on page 2: Q2FY26 was Rs 432 crore and Q2FY27 was Rs 504 crore, reflecting a YoY growth of 16%. For H1FY27, revenue reached Rs 1,013 crore, up 20% compared to Rs 841 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIERAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_4o"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4q">Asia Branded Generics:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue was Rs 366 crore, posting a YoY increase of 18% over Rs 310 crore in Q2FY26. For H1FY27, revenue stood at Rs 621 crore, higher by 1% from Rs 614 crore in H1FY26 as previous quarters faced war-impacted supply chain bottlenecks.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIERAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_4r"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4t">Africa Branded Generics:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue was Rs 312 crore, a significant YoY increase of 41% from Rs 221 crore in Q2FY26. For H1FY27, revenue expanded YoY by 35% to Rs 607 crore from Rs 449 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIERAG" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_4u"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4w">US Generics:<!--TgQPHd|||[]--></strong> For Q2FY27, US business delivered Rs 484 crore, up 41% YoY from Rs 344 crore in Q2FY26. For H1FY27, revenue reached Rs 971 crore, marking a 49% growth over Rs 653 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIERAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VEfGuf_4x"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="VEfGuf_4z">Africa Institution:<!--TgQPHd|||[]--></strong> For Q2FY27, institution sales surged 259% YoY to Rs 116 crore from Rs 32 crore in Q2FY26. For H1FY27, sales were Rs 187 crore, expanding 164% YoY from Rs 71 crore in H1FY26.</li> </ul> </li> </ul> <p><a class="lb" href="/get-document/post/pdf/5918660/" target="_blank">Result PDF</a></p>

• Trendlyne
• 2 days 4 hours ago